| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K33199242 |
| PharmacoGx | BRD-K33199242 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPO | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | GOLGA8Q | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | COX7C | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ALDH1L2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | DUT | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | DIAPH1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | FOSL1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | ARL3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | AVIL | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | HTRA1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
